These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6491899)

  • 1. Definition of pharmacokinetic parameters: influence of the sampling site.
    Weiss M
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):167-75. PubMed ID: 6491899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moments of physiological transit time distributions and the time course of drug disposition in the body.
    Weiss M
    J Math Biol; 1982; 15(3):305-18. PubMed ID: 7153675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling of initial distribution of drugs following intravenous bolus injection.
    Weiss M
    Eur J Clin Pharmacol; 1983; 24(1):121-6. PubMed ID: 6832194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. I. Log-convex drug disposition curves.
    Weiss M
    J Pharmacokinet Biopharm; 1986 Dec; 14(6):635-57. PubMed ID: 3820094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state distribution volume in physiologic multi-organ systems.
    Weiss M
    Biopharm Drug Dispos; 1983; 4(2):151-6. PubMed ID: 6882883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination.
    Berezhkovskiy LM
    Xenobiotica; 2016; 46(6):477-82. PubMed ID: 26406808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls and valid approaches to pharmacokinetic analysis of mean concentration data following intravenous administration.
    Cocchetto DM; Wargin WA; Crow JW
    J Pharmacokinet Biopharm; 1980 Dec; 8(6):539-52. PubMed ID: 7229907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of statistical moments and steady-state volume of distribution for a drug given by intravenous infusion.
    Chan KK; Gibaldi M
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):551-8. PubMed ID: 7166738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
    Ye M; Nagar S; Korzekwa K
    Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An estimation method of the clearance for a one-compartment model of a single bolus intravenous injection by a single sampling.
    Funatogawa T; Funatogawa I
    J Biopharm Stat; 2012; 22(1):43-53. PubMed ID: 22204526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-independent assessment of accumulation kinetics based on moments of drug disposition curves.
    Weiss M
    Eur J Clin Pharmacol; 1984; 27(3):355-9. PubMed ID: 6510464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance.
    Gibaldi M; Koup JR
    Eur J Clin Pharmacol; 1981; 20(4):299-305. PubMed ID: 7308282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single pass mean residence time in peripheral tissues: a distribution parameter intrinsic to the tissue affinity of a drug.
    Veng-Pedersen P; Gillespie WR
    J Pharm Sci; 1986 Dec; 75(12):1119-26. PubMed ID: 3559920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of gamma distributed residence times in pharmacokinetics.
    Weiss M
    Eur J Clin Pharmacol; 1983; 25(5):695-702. PubMed ID: 6662168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physiological significance of total body clearance in pharmacokinetic studies.
    Chiou WL
    J Clin Hosp Pharm; 1982 Mar; 7(1):25-30. PubMed ID: 7096575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-free evaluation and mean-time concept in pharmacokinetics.
    Brockmeier D
    Methods Find Exp Clin Pharmacol; 1986 Oct; 8(10):593-602. PubMed ID: 3784698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of absolute bioavailability assuming steady state apparent volume of distribution remains constant.
    Collier PS; Riegelman S
    J Pharmacokinet Biopharm; 1983 Apr; 11(2):205-14. PubMed ID: 6886975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approach.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 Mar; 25(2):99-101. PubMed ID: 14872558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Sampling Site and Fluid Flow on the Accuracy of Total Body Clearance Calculation.
    LaPorte B; Musteata FM
    J Pharm Sci; 2020 Jun; 109(6):2079-2089. PubMed ID: 32169313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.